| John J Williams, MD | |
|
1301 Barbara Jordan Blvd., Suite 300, Austin, TX 78723 | |
| (512) 478-8116 | |
| (512) 478-9368 |
| Full Name | John J Williams |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine |
| Location | 1301 Barbara Jordan Blvd., Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720052079 | NPI | - | NPPES |
| 1624223-02 | Medicaid | TX | |
| 87W190 | Other | TX | BCBS INDIVIDUAL # |
| 1624223-07 | Other | TX | MEDICAID CSHCN ROT |
| 162422303 | Other | TX | MEDICAID CSHCN |
| 1624223-06 | Medicaid | TX |
| Entity Name | Central Texas Pediatric Orthopedics And Scoliosis Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144294661 PECOS PAC ID: 4183670367 Enrollment ID: O20050330001096 |
News Archive
A research team led by Nancy Speck, PhD, Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
Transformation in U.S. health care delivery systems and associated quality measurements in the wake of reforms implemented by Affordable Care Act might be most impactful within community health centers (CHC).
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Williams, MD 1301 Barbara Jordan Blvd., Suite 300, Austin, TX 78723 Ph: (512) 478-8116 | John J Williams, MD 1301 Barbara Jordan Blvd., Suite 300, Austin, TX 78723 Ph: (512) 478-8116 |
News Archive
A research team led by Nancy Speck, PhD, Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has identified the location and developmental timeline in which a majority of bone marrow stem cells form in the mouse embryo.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.
Transformation in U.S. health care delivery systems and associated quality measurements in the wake of reforms implemented by Affordable Care Act might be most impactful within community health centers (CHC).
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA.
› Verified 9 days ago
Michael W Burris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way, Suite 370, Austin, TX 78758 Phone: 512-617-1989 Fax: 512-617-2065 | |
Dr. William Parker Abblitt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy Ste 200, Austin, TX 78759 Phone: 512-439-1000 | |
Matthew David Ellington, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd, Suite 300, Austin, TX 78723 Phone: 512-478-8116 Fax: 512-478-9368 | |
Ryan Michael Tibbetts, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy, Ste 200, Austin, TX 78759 Phone: 512-439-1000 Fax: 512-439-1081 | |
Dr. Kevin J. Bozic, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1301 W 38th St, Ste 102, Austin, TX 78705 Phone: 512-454-4561 Fax: 512-406-7330 | |
Dr. Eugene P Schoch Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1015 East 32nd St, Suite 101, Austin, TX 78705 Phone: 512-477-6341 Fax: 512-477-1148 | |
Dr. Kathleen Dolores Rickert-madden, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 300, Austin, TX 78723 Phone: 512-478-8116 Fax: 512-478-9368 |